In a strategic move to bolster its intellectual property capabilities, Honigman LLP has announced the recruitment of Joseph Mahoney and Erick Palmer as partners to its IP litigation practice group in Chicago. The announcement, made by the firm on Monday, marks a significant enhancement of their life sciences sector expertise.
Mahoney comes equipped with a robust background in advising clients across biotechnology, chemical, medical device, and pharmaceutical industries. His experience encompasses handling complex patent matters, including portfolio development, litigation strategies, and due diligence for acquisitions and licenses. His acumen will be particularly invaluable as clients navigate the intricacies of inter partes reviews and Orange Book listings. For more detailed insights on Mahoney’s specific expertise, details are available through the firm’s announcement.
Erick Palmer’s practice is centered around patent disputes, with a focus on representing clients in federal courts and before the Patent Trial and Appeal Board. His domain expertise spans pharmaceuticals, biotechnology, chemicals, food sciences, nutraceuticals, and medical devices, providing a broad spectrum of sector expertise.
The arrival of both Mahoney and Palmer reflects Honigman LLP’s commitment to expanding its footprint in the IP litigation arena, particularly within life sciences—a sector that continues to witness significant growth and legal complexities. Their combined expertise is set to strengthen the firm’s ability to meet the evolving needs of its clients. The firm’s latest moves can be explored further in the full article on Bloomberg Law.